1,110
Participants
Start Date
September 21, 2016
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
Tazarotene Cream 0.1%
Tazarotene Cream 0.1% applied to cover the affected areas of the face once daily for 84 +/- 4 days.
Tazorac®
Tazorac® applied to cover the affected areas of the face once daily for 84 +/- 4 days.
Placebo
Placebo (vehicle of the test product) applied to cover the affected areas of the face once daily for 84 +/- 4 days.
Fougera Investigational Site, Upper Saint Clair
Fougera Investigational Site, Hazleton
Fougera Investigational Site, High Point
Fougera Investigational Site, Miami
Fougera Investigational Site, Miramar
Fougera Investigational Site, Coral Gables
Fougera Investigational Site, Miami Gardens
Fougera Investigational Site, Sweetwater
Fougera Investigational Site, Miami
Fougera Investigational Site, Chattanooga
Fougera Investigational Site, Plainfield
Fougera Investigational Site, Hot Springs
Fougera Investigational Site, Conway
Fougera Investigational Site, Austin
Fougera Investigational Site, Tucson
Fougera Investigational Site, Los Angeles
Fougera Investigational Site, Long Beach
Fougera Investigational Site, Long Beach
Fougera Investigational Site, North Hollywood
Fougera Investigational Site, Upland
Fougera Investigational Site, West Covina
Fougera Investigational Site, La Mesa
Fougera Investigational Site, San Diego
Fougera Investigational Site, Anaheim
Fougera Investigational Site, San Ramon
Lead Sponsor
Fougera Pharmaceuticals Inc.
INDUSTRY